Start with what you know right now, even before every detail is final. Leaders should talk with finance and adjacent teams to separate decisions that need certainty from the work that holds value ...

Masters Pharmaceutical is a secondary pharmaceutical wholesaler founded in 2002. Since joining McKesson in 2018, the business has added scale, technology and supply chain capabilities to its ...

IRVING, Texas, October 21, 2026 — The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 94 cents per share of common stock. The dividend will be payable on ...

At the upcoming Becker's 14th Annual CEO + CFO Roundtable, November 2-5 in Chicago, IL, Spencer Williamson, Senior Vice President, National Accounts & Government, and Omar Hafez, Vice President and ...

Pharmacists help patients overcome barriers that can delay or disrupt treatment. Access challenges such as prior authorizations, coverage requirements and affordability concerns can stand between ...

October is American Pharmacists Month, a time to recognize and celebrate pharmacists for the incredible impact they make every day across healthcare. It also includes Women Pharmacist Day and National ...

Every supply chain decision ultimately affects patient care. Drug shortages can delay, alter, or disrupt treatment, which makes resilience critical across the healthcare ecosystem. Modern technology ...

Pharmacies operate within a complex environment of contracts, credentialing requirements, rules and reimbursement systems that few outside the industry ever see. Pharmacy Services Administrative ...

See how Ontada’s ON.Journey delivers research-grade, longitudinal community oncology data to help life sciences teams generate real-world evidence.

Hospital pharmacists help patients navigate treatment decisions, care transitions and access challenges across an increasingly complex healthcare system. Beyond dispensing medications, pharmacists ...

Oncologists are treating nearly twice as many patients with cell and gene therapies (CGTs) as they were in 2024, and 97% say CGTs could offer some patients the best chance for a cure. This year, the ...